Francesca Carobolante
Francesca Carobolante publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Multiple Myeloma Research and Treatments, Hematopoietic Stem Cell Transplantation and Chronic Myeloid Leukemia Treatments.
- World rank
- #2,639,557 of 7,710,434 ranked researchers
- Rank in Italy
- #88,762 of 242,206
- Works
- 16
- Citations
- 903
- Citations per work
- 56.4
What does Francesca Carobolante research?
Francesca Carobolante's work is mostly in Medicine (75%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1275.0%
- Medicine1275.0%
- Everything else425.0%
- 1Hematology35% of their works
- 2Genetics10% of their works
- 3Public Health, Environmental and Occupational Health8% of their works
- 4Oncology8% of their works
- 5Emergency Medicine6% of their works
- 6Pediatrics, Perinatology and Child Health6% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Hematological disorders and diagnostics
- Acute Myeloid Leukemia Research
- Childhood Cancer Survivors' Quality of Life
- Amyloidosis: Diagnosis, Treatment, Outcomes
Which keywords describe Francesca Carobolante's research?
The keywords of their largest research topics: Minimal Residual Disease, Hematopoietic Stem Cells, Prognostic Factors, Diagnosis Criteria, International Myeloma Working Group, Acute Lymphoblastic Leukemia, BCR-ABL and Bone Marrow Niche.
- Cardiac Amyloidosis
- FDG PET/CT
- Bone Marrow Biopsy
- AML
- Graft-versus-Host Disease
- Bone Marrow Niche
- Acute Lymphoblastic Leukemia
- Diagnosis Criteria
- Hematopoietic Stem Cells
- Minimal Residual Disease
- Prognostic Factors
- International Myeloma Working Group
- BCR-ABL
- Childhood Cancer
- Imatinib
- Acute Myeloid Leukemia
- Childhood Cancer Survivor Study
- Pediatric Quality of Life Inventory
- Transthyretin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Minimal Residual Disease92 topics
- Hematopoietic Stem Cells72 topics
- Prognostic Factors72 topics
- Diagnosis Criteria51 topic
- International Myeloma Working Group51 topic
- Acute Lymphoblastic Leukemia41 topic
- BCR-ABL41 topic
- Bone Marrow Niche41 topic
- Childhood Cancer41 topic
- Graft-versus-Host Disease41 topic
- Imatinib41 topic
- AML31 topic
- Acute Myeloid Leukemia31 topic
- Bone Marrow Biopsy31 topic
- Childhood Cancer Survivor Study31 topic
- FDG PET/CT31 topic
- Pediatric Quality of Life Inventory31 topic
- Cardiac Amyloidosis21 topic
- Transthyretin21 topic
Where does Francesca Carobolante work?
Francesca Carobolante's main affiliation in the publication record is Ospedale dell' Angelo, Italy.
How many publications and citations does Francesca Carobolante have?
OpenAlex counts 16 works and 903 citations for Francesca Carobolante, an h-index of 8, ranking #2,639,557 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Francesca Carobolante. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.